COMMERCIALIZATION AGREEMENTCommercialization Agreement • February 24th, 2021 • Tandem Diabetes Care Inc • Surgical & medical instruments & apparatus • California
Contract Type FiledFebruary 24th, 2021 Company Industry JurisdictionThis Commercialization Agreement (this “Agreement”) is made and entered into on November 20, 2020 (the “Effective Date”) by and between Tandem Diabetes Care, Inc, having a principal place of business at 11075 Roselle St., San Diego, CA 92121 (“Tandem”) and DexCom, Inc., a Delaware corporation having a principal place of business at 6340 Sequence Drive, San Diego, CA 92121 (“DexCom”). Tandem and DexCom may be referred to in this Agreement individually as a “Party” and collectively as the “Parties”.
DEVELOPMENT AGREEMENTDevelopment Agreement • February 24th, 2021 • Tandem Diabetes Care Inc • Surgical & medical instruments & apparatus • California
Contract Type FiledFebruary 24th, 2021 Company Industry JurisdictionThis Development Agreement (this “Agreement”) is made and entered into on November 20, 2020 (the “Effective Date”) by and between Tandem Diabetes Care, Inc, having a principal place of business at 11075 Roselle St., San Diego, CA 92121 (“Tandem”) and DexCom, Inc., a Delaware corporation having a principal place of business at 6340 Sequence Drive, San Diego, CA 92121 (“DexCom”). Tandem and DexCom may be referred to in this Agreement individually as a “Party” and collectively as the “Parties”.